Skip Navigation LinksHome > December 2011 - Volume 21 - Issue 6 > Genetic markers anticipate response to citalopram in a major...
Psychiatric Genetics:
doi: 10.1097/YPG.0b013e3283480485
Original Articles

Genetic markers anticipate response to citalopram in a majority of patients

Alemi, Farrokha; Zargoush, Manaff; Erdman, Harolda; Vang, Jeea; Epstein, Steveb; Ayman, Fanousb,c,d,e

Collapse Box

Abstract

Objective: Scientists have concluded that genetic profiles cannot predict a large percentage of variation in response to citalopram, a common antidepressant. Using the same data, we examined if a different conclusion can be arrived at when the results are personalized to fit specific patients.

Methods: We used data available through the Sequenced Treatment Alternatives to Relieve Depression database. We created three boosted Classification and Regression Trees to identify 16 subgroups of patients, among whom anticipation of positive or negative response to citalopram was significantly different from 0.5 (P≤0.1).

Results: In a 10-fold cross-validation, this ensemble of trees made no predictions in 33% of cases. In the remaining 67% of cases, it accurately classified response to citalopram in 78% of cases.

Conclusion: For the majority of the patients, genetic markers can be used to guide selection of citalopram. The rules identified in this study can help personalize prescription of antidepressants.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.